EP0471468A1 - Behälter für reaktive pharmazeutische Produkte - Google Patents
Behälter für reaktive pharmazeutische Produkte Download PDFInfo
- Publication number
- EP0471468A1 EP0471468A1 EP91306932A EP91306932A EP0471468A1 EP 0471468 A1 EP0471468 A1 EP 0471468A1 EP 91306932 A EP91306932 A EP 91306932A EP 91306932 A EP91306932 A EP 91306932A EP 0471468 A1 EP0471468 A1 EP 0471468A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pharmaceutically active
- active compound
- container according
- container
- polyester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
Definitions
- This invention relates to improved containers for reactive pharmaceutically active compounds, more particularly to improved containers for pharmaceutically active compounds having a primary or secondary amine group.
- the present invention provides a container including outlet means, which comprises plastics components and holds a pharmaceutically active compound having a primary or secondary amine group; characterized in that some or all of the plastics components which come into contact with the pharmaceutically active compound during storage or release through the outlet means are made from polyester.
- the pharmaceutically active compound may be present as a salt, including an acid addition salt formed with the amine group, for example a hydrochloride, hydrobromide or hydrosulphate.
- the pharmaceutically active compound will often be present as a component of a pharmaceutical formulation.
- containers according to the present invention are particularly useful in the storage and administration to the lungs by inhalation of pharmaceutically active compounds having a primary or secondary amine group.
- Inhalation devices for use in association with a pressurized aerosol cannister of medicament provided with a valve have been used in the administration of medicaments to the lung by inhalation for some time.
- a preferred type of container is therefore a pressurized aerosol cannister provided with a valve.
- Pressurized aerosol cannisters are often made from a metal, for example aluminium, in which case some or all of the components of the valve will be made of polyester.
- Suitable valves for pressurized aerosol cannisters include metering valves, in particular those described in European Patent Application No 143577, which application is incorporated herein by reference.
- the pharmaceutically active compound is desirably dispersed in a pharmaceutically acceptable aerosol propellant, for example a chlorofluorocarbon or a hydrofluorocarbon such as trifluorochloromethane, dichlorotetrafluoroethane or dichlorodifluoromethane.
- a pharmaceutically acceptable aerosol propellant for example a chlorofluorocarbon or a hydrofluorocarbon such as trifluorochloromethane, dichlorotetrafluoroethane or dichlorodifluoromethane.
- a surfactant for example sorbitan trioleate.
- Containers according to the invention are particularly useful in the storage and administration of pharmaceutically active phenylethylamine derivatives, including those in which the phenyl ring is substituted by hydroxy.
- examples of such compounds include isoprenaline, salbutamol, orciprenaline and particularly reproterol.
- the container also to hold a prophylactic anti-asthma agent.
- Prophylactic anti-asthma agents include nedocromil sodium and sodium cromoglycate.
- Suitable polyester materials for use in the invention include polyethylene terephthalate and particularly polybutylene terephthalate.
- a specific example of a container according to the invention is a pressurized aerosol cannister provided with a valve, the cannister being made of aluminium and the valve being that described in EP 143577 with reference to Figures 1 and 2, but with the circular cup (1) and valve bush (3) being made of polybutylene terephthalate, and the cannister containing the following formulation:
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Glass Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9017673 | 1990-08-11 | ||
GB909017673A GB9017673D0 (en) | 1990-08-11 | 1990-08-11 | Container |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0471468A1 true EP0471468A1 (de) | 1992-02-19 |
EP0471468B1 EP0471468B1 (de) | 1994-12-07 |
Family
ID=10680548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP91306932A Expired - Lifetime EP0471468B1 (de) | 1990-08-11 | 1991-07-29 | Behälter für reaktive pharmazeutische Produkte |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0471468B1 (de) |
AT (1) | ATE114980T1 (de) |
DE (1) | DE69105663T2 (de) |
GB (1) | GB9017673D0 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997009034A1 (en) * | 1995-09-04 | 1997-03-13 | Bioglan Laboratories Ltd. | Pharmaceutical compositions and devices for their administration |
US6413496B1 (en) | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451641A (en) * | 1983-06-13 | 1984-05-29 | Eastman Kodak Company | Radiation-resistant container material of poly(tetramethylene terephthalate) |
EP0196288A2 (de) * | 1985-03-29 | 1986-10-01 | Aktiebolaget Draco | Dosierungsverpackung |
-
1990
- 1990-08-11 GB GB909017673A patent/GB9017673D0/en active Pending
-
1991
- 1991-07-29 EP EP91306932A patent/EP0471468B1/de not_active Expired - Lifetime
- 1991-07-29 DE DE69105663T patent/DE69105663T2/de not_active Expired - Lifetime
- 1991-07-29 AT AT91306932T patent/ATE114980T1/de not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451641A (en) * | 1983-06-13 | 1984-05-29 | Eastman Kodak Company | Radiation-resistant container material of poly(tetramethylene terephthalate) |
EP0196288A2 (de) * | 1985-03-29 | 1986-10-01 | Aktiebolaget Draco | Dosierungsverpackung |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997009034A1 (en) * | 1995-09-04 | 1997-03-13 | Bioglan Laboratories Ltd. | Pharmaceutical compositions and devices for their administration |
US6413496B1 (en) | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
Also Published As
Publication number | Publication date |
---|---|
DE69105663T2 (de) | 1995-05-18 |
EP0471468B1 (de) | 1994-12-07 |
ATE114980T1 (de) | 1994-12-15 |
DE69105663D1 (de) | 1995-01-19 |
GB9017673D0 (en) | 1990-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2402300C (en) | Fluorocarbon aerosol medicaments | |
US9650203B2 (en) | Medicinal aerosols and methods of delivery thereof | |
AU764696C (en) | Pressurised metered dose inhalers (MDI) | |
EP1306082B1 (de) | Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen | |
CA2125665C (en) | Medicaments | |
SK13342003A3 (sk) | Lekárske aerosólové prípravky | |
HUT68986A (en) | Aerosol formulations containing beclomethasone dipropionate and process for production of them | |
EP0471468B1 (de) | Behälter für reaktive pharmazeutische Produkte | |
KR0175164B1 (ko) | 에어로졸 약물 제제 | |
MXPA00012388A (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
ZA200104222B (en) | Pressurised metered dose inhalers (MDI). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910806 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT CH DE LI |
|
17Q | First examination report despatched |
Effective date: 19940118 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT CH DE LI |
|
REF | Corresponds to: |
Ref document number: 114980 Country of ref document: AT Date of ref document: 19941215 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 69105663 Country of ref document: DE Date of ref document: 19950119 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20100714 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20100721 Year of fee payment: 20 Ref country code: AT Payment date: 20100712 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69105663 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69105663 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20110730 |